Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of FF/VI vs VI in COPD
NCT02105974Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2014
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 3 trial of fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Apr 2014; status: completed.
02
Drugs
fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02105974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02105974.